The influence of 21-gene recurrence score assay on chemotherapy use in a population-based sample of breast cancer patients

Abstract

To quantify the influence of RS assay on changing chemotherapy plans in a general practice setting using causal inference methods. We surveyed 3880 newly diagnosed breast cancer patients in Los Angeles and Georgia in 2013–14. We used inverse propensity weighting and multiple imputations to derive complete information for each patient about treatment status… (More)
DOI: 10.1007/s10549-016-4086-3

Topics

5 Figures and Tables

Cite this paper

@article{Li2016TheIO, title={The influence of 21-gene recurrence score assay on chemotherapy use in a population-based sample of breast cancer patients}, author={Yun Li and Allison W. Kurian and Irina Bondarenko and Jeremy M. G. Taylor and Reshma Jagsi and Kevin C. Ward and A. J. S. Hamilton and Steven J. Katz and Timothy P Hofer}, journal={Breast Cancer Research and Treatment}, year={2016}, volume={161}, pages={587-595} }